OverTTuRe: An Observational Multi-Country Study Collecting Real-World Secondary Data on the Characteristics, Treatment Patterns and Outcomes of Patients with ATTR amyloidosis. - OverTTuRe

Study identifier:D8450R00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

OverTTuRe: An Observational Multi-Country Study Collecting Real-World Secondary Data on the Characteristics, Treatment Patterns and Outcomes of Patients with ATTR amyloidosis.

Medical condition

ATTR amyloidosis

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

55000

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 21 Aug 2023
Estimated Primary Completion Date: 15 Jan 2025
Estimated Study Completion Date: 15 Jan 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria